Acute myeloid leukemia (AML) is a heterogeneous diseasegroup morphologically classified, based on the French–American–British (FAB) classification, into eight main subgroupsdefined as subtypes M0–M7. Besides morphologic differences,genetic abnormalities have been recognized; cytogenetics andmolecular analyses are currently used to identify subgroups ofAML with different clinical prognosis. However, in spite ofavailable prognostic factors, accurate prediction of risk fortreatment failure or relapse is not completely satisfactory.In order to improve risk assignment and develop new therapeuticstrategies, gene expression profiling and proteomicanalysis seem to offer important improvements in leukemiaclassification.

Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia / Zangrando, A; Luchini, A; Buldini, B; Rondelli, R; Pession, A; Bicciato, Silvio; TE KRONNIE, G; Basso, G.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 20:5(2006), pp. 888-891. [10.1038/sj.leu.2404175]

Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia

BICCIATO, Silvio;
2006

Abstract

Acute myeloid leukemia (AML) is a heterogeneous diseasegroup morphologically classified, based on the French–American–British (FAB) classification, into eight main subgroupsdefined as subtypes M0–M7. Besides morphologic differences,genetic abnormalities have been recognized; cytogenetics andmolecular analyses are currently used to identify subgroups ofAML with different clinical prognosis. However, in spite ofavailable prognostic factors, accurate prediction of risk fortreatment failure or relapse is not completely satisfactory.In order to improve risk assignment and develop new therapeuticstrategies, gene expression profiling and proteomicanalysis seem to offer important improvements in leukemiaclassification.
2006
20
5
888
891
Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia / Zangrando, A; Luchini, A; Buldini, B; Rondelli, R; Pession, A; Bicciato, Silvio; TE KRONNIE, G; Basso, G.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 20:5(2006), pp. 888-891. [10.1038/sj.leu.2404175]
Zangrando, A; Luchini, A; Buldini, B; Rondelli, R; Pession, A; Bicciato, Silvio; TE KRONNIE, G; Basso, G.
File in questo prodotto:
File Dimensione Formato  
Leukemia_2006.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 196.31 kB
Formato Adobe PDF
196.31 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/421614
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact